Chloroquine and hydroxychloroquine in the treatment of COVID-19 with or without diabetes: A systematic search and a narrative review with a special reference to India and other developing countries

Wu, 2020, Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese center for disease control and prevention, J Am Med Assoc, 10.1001/jama.2020.2648 Gupta, 2020, Clinical considerations for patients with diabetes in times of COVID-19 epidemic, Diabetes, Metab Syndrome Clin Res Rev, 14, 211, 10.1016/j.dsx.2020.03.002 Lai, 2020, Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): facts and myths, J Microbiol Immunol Infect, 30040 LiuW, 2020, Learning from the past: possible urgent prevention and treatment options for severe acute respiratory infections caused by 2019-nCoV, Chembiochem, 4 Lai, 2020, Drug treatment options for the 2019-new coronavirus (2019-nCoV), Biosci Trends Wang, 2020, Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro, Cell Res Colson, 2020, Chloroquine for the 2019 novel coronavirus, Int J Antimicrob Agents, 10.1016/j.ijantimicag.2020.105923 Zhou, 2016, Glycopeptide antibiotics potently inhibit cathepsin L in the late endosome/lysosome and block the entry of Ebola virus, middle east respiratory syndrome coronavirus (MERS-CoV), and severe acute respiratory syndrome coronavirus (SARS-CoV), J Biol Chem, 291, 9218e32, 10.1074/jbc.M116.716100 Colson, 2020, Chloroquine and hydroxychloroquine as available weapons to fight COVID-19, Int J Antimicrob Agents, 105932, 10.1016/j.ijantimicag.2020.105932 Biot, 2006, Design and synthesis of hydroxyferroquine derivatives with antimalarial and antiviral activities, J Med Chem, 49, 2845, 10.1021/jm0601856 Liu, 2020, Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro, Cell Discov, 6, 16, 10.1038/s41421-020-0156-0 Yao, 2020, In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Clin Infect Dis, 10.1093/cid/ciaa237 Raoult, 1990, Bactericidal effect of doxycycline associated with lysosomotropic agents on Coxiella burnetii in P388D1 cells, Antimicrob Agents Chemother, 34, 1512, 10.1128/AAC.34.8.1512 Boulos A, Rolain JM, Raoult D. Antibiotic susceptibility of Tropheryma whipplei in MRC5 cells. Antimicrob Agents. Marmor, 2016 Huang, 2020, Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China, Lancet, 395, 497, 10.1016/S0140-6736(20)30183-5 Gao, 2020, Breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies, Biosci Trends, 10.5582/bst.2020.01047 Gautret, 2020, Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open label non-randomized clinical trial, Int J Antimicrob Agents, 10.1016/j.ijantimicag.2020.105949 Touret, 2020, Of chloroquine and COVID-19, Antivir Res, 177, 104762, 10.1016/j.antiviral.2020.104762 2020, Zhonghua Jiehe He Huxi Zazhi, 43, 185 Paton, 2011, Chloroquine for influenza prevention: a randomised, double-blind, placebo controlled trial, Lancet Infect Dis, 11, 677, 10.1016/S1473-3099(11)70065-2 Tricou, 2010, A randomized controlled trial of chloroquine for the treatment of dengue in Vietnamese adults, PLoS Neglected Trop Dis, 4, e785, 10.1371/journal.pntd.0000785 Falzarano, 2015, Lack of protection against ebola virus from chloroquine in mice and hamsters, Emerg Infect Dis, 21, 1065, 10.3201/eid2106.150176 Vigerust, 2007, Chloroquine is effective against influenza A virus in vitro but not in vivo, Influenza Other Respir Viruses, 1, 189, 10.1111/j.1750-2659.2007.00027.x Pallister, 2009, Chloroquine administration does not prevent Nipah virus infection and disease in ferrets, J Virol, 83, 11979, 10.1128/JVI.01847-09 Seth, 1999, Acceleration of viral replication and up-regulation of cytokine levels by antimalarials: implications in malaria-endemic areas, Am J Trop Med Hyg, 61, 180, 10.4269/ajtmh.1999.61.180 Roques, 2018, Paradoxical effect of chloroquine treatment in enhancing chikungunya virus infection, Viruses, 10, 10.3390/v10050268 Chauhan, 2015, The enigma of the clandestine association between chloroquine and HIV-1 infection, HIV Med, 16, 585, 10.1111/hiv.12295 Helal, 2016, Hydroxychloroquine augments early virological response to pegylated interferon plus ribavirin in genotype-4 chronic hepatitis C patients, J Med Virol, 88, 2170, 10.1002/jmv.24575 Liu, 2018, Chloroquine and hydroxychloroquine are associated with reduced cardiovascular risk: a systematic review and meta-analysis, Drug Des Dev Ther, 12, 1685, 10.2147/DDDT.S166893 Cortegiani, 2020, A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19, J Crit Care, 30390